gefitinib

Ukraine

Drugs containing this active substance

  • GEFITINIB-VISTA

    The drug is prescribed for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have specific activating mutations of the epidermal growth factor receptor (EGFR).

    Form: tablets, film-coated

    Active substance Dosage
    gefitinib 250 mg

    ATC: L01XE02

    Manufacturer: Synthon Hispania, S.L. (division responsible for full production cycle)